financetom
LFMD
financetom
/
Healthcare
/
LFMD
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
LifeMD, Inc.LFMD
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including urgent and primary care, men's and women's health, and dermatology, chronic care management, and others in the United States.

The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and food and drug administration approved medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and NavaMD, a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers.

It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents.

The company sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels.

The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021.

LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Latest News >
BRIEF-Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
BRIEF-Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Dec 30, 2024
Dec 30 (Reuters) - Marinus Pharmaceuticals ( MRNS ): * IMMEDICA TO ACQUIRE BIOPHARMACEUTICAL COMPANY MARINUS PHARMACEUTICALS, INC. * MARINUS PHARMACEUTICALS INC ( MRNS ) - IMMEDICA TO ACQUIRE MARINUS FOR $0.55 PER SHARE Source text: Further company coverage: ...
Emeren Group Signs Seven-Year Power Purchase Agreement in Poland; Shares Up Pre-Bell
Emeren Group Signs Seven-Year Power Purchase Agreement in Poland; Shares Up Pre-Bell
Dec 30, 2024
07:15 AM EST, 12/30/2024 (MT Newswires) -- Emeren Group ( SOL ) said Monday it signed a seven-year power purchase agreement for a 15,000 MWh solar farm in Poland. Emeren ( SOL ) said the solar farm will supply energy under a pay-as-produced agreement to the Polish subsidiary of a multinational consumer goods business. Financial details of the agreement were...
Novartis Says Gene Therapy for Spinal Muscular Atrophy Meets Primary Endpoint in Phase 3 Study
Novartis Says Gene Therapy for Spinal Muscular Atrophy Meets Primary Endpoint in Phase 3 Study
Dec 30, 2024
07:12 AM EST, 12/30/2024 (MT Newswires) -- Novartis ( NVS ) said in a regulatory filing Monday that its phase 3 study evaluating its one-time gene therapy intrathecal onasemnogene abeparvovec, or OAV101 IT, met its primary endpoint. Based on the results, there was an increase from baseline in the Hammersmith Functional Motor Scale - Expanded, or HFMSE, total score in...
BRIEF-Wabtec Acquires Bloom Engineering To Strengthen Portfolio
BRIEF-Wabtec Acquires Bloom Engineering To Strengthen Portfolio
Dec 30, 2024
Dec 30 (Reuters) - Westinghouse Air Brake Technologies Corp ( WAB ): * WABTEC ACQUIRES BLOOM ENGINEERING TO STRENGTHEN ITS HEAT TRANSFER AND ENERGY SOLUTION PORTFOLIO * WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP ( WAB ) - WABTEC EXPECTS BLOOM TO BE IMMEDIATELY ACCRETIVE TO EPS * WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP ( WAB ) - WABTEC ACQUIRED BLOOM FOR $69...
Copyright 2023-2026 - www.financetom.com All Rights Reserved